Skopos Labs, Inc. Prothena Corp Public LTD CO Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Skopos Labs, Inc. holds 161 shares of PRTA stock, worth $2,545. This represents 0.0% of its overall portfolio holdings.
Number of Shares
161Holding current value
$2,545% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
185Shares Held
42.8MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$183 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$66.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$61 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$60.4 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$27.5 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $742M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...